Genetic risk test for periodontal disease highlighted during ADA annual meeting

Interleukin’s Chief Executive Officer Kenneth S. Kornman, DDS, PhD presented on the topic of genetic testing as part of risk stratification for preventive dental care at the 2014 ADA annual meeting.

Oct 14th, 2014
Kkornman
The topic of genetics in relation to periodontal disease was a focus at the 2014 American Dental Association (ADA) Annual Meeting.

During a Saturday morning continuing education course titled, “Introduce Scientific Advances Into Your Clinical Practice”, Interleukin’s Chief Executive Officer Kenneth S. Kornman, DDS, PhD presented on the topic of genetic testing as part of risk stratification for preventive dental care.

Heightened interest in the subject results from the landmark research published in the Journal of Dental Research in June 2013. The University of Michigan Personalized Prevention Study provided important new insights into the prevention of periodontal disease and the significant opportunity to improve oral health through a personalized approach to preventive care that includes genetics. Last month, the study’s authors received the 2014 Clinical Research Award from the American Academy of Periodontology demonstrating the impact of this research on clinical dentistry.

Related Articles
What’s new in Perio? Study finds link between periodontal disease and atherosclerosis
American Academy of Periodontology recognizes member achievements

More in Curing Lights